94 related articles for article (PubMed ID: 25921553)
1. Rifampicin-dependent antibodies target glycoprotein IIb/IIIa and cause clearance of human platelets in NOD/SCID mice.
Sun P; Wu G; Gao RL; Liu S; Phillips WD; Liang SX
Br J Haematol; 2016 Jan; 172(1):137-40. PubMed ID: 25921553
[No Abstract] [Full Text] [Related]
2. Platelet-associated anti-glycoprotein (GP) IIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura mainly recognize cation-dependent conformations: comparison with the epitopes of serum autoantibodies.
Kosugi S; Tomiyama Y; Shiraga M; Kashiwagi H; Mizutani H; Kanakura Y; Kurata Y; Matsuzawa Y
Thromb Haemost; 1996 Feb; 75(2):339-45. PubMed ID: 8815587
[TBL] [Abstract][Full Text] [Related]
3. In-vitro inhibition of antiplatelet autoantibodies by intravenous immunoglobulins and Rh immunoglobulins.
Mehta YS; Badakere SS
J Postgrad Med; 1996; 42(2):46-9. PubMed ID: 9715299
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet antibodies in childhood idiopathic thrombocytopenic purpura.
Ozsoylu S
Am J Hematol; 1996 Apr; 51(4):328. PubMed ID: 8602636
[No Abstract] [Full Text] [Related]
5. Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP).
Najaoui A; Bakchoul T; Stoy J; Bein G; Rummel MJ; Santoso S; Sachs UJ
Eur J Haematol; 2012 Feb; 88(2):167-74. PubMed ID: 21985182
[TBL] [Abstract][Full Text] [Related]
6. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in production of anti-platelet autoantibody.
Kuwana M; Kaburaki J; Ikeda Y
J Clin Invest; 1998 Oct; 102(7):1393-402. PubMed ID: 9769332
[TBL] [Abstract][Full Text] [Related]
7. Circulating antiplatelet antibody specificity in children with immune thrombocytopenic purpura at onset.
Biglino P; Perutelli P; Mori PG
Haematologica; 1997; 82(1):127. PubMed ID: 9107104
[No Abstract] [Full Text] [Related]
8. Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia.
Vollenberg R; Jouni R; Norris PAA; Burg-Roderfeld M; Cooper N; Rummel MJ; Bein G; Marini I; Bayat B; Burack R; Lazarus AH; Bakchoul T; Sachs UJ
Haematologica; 2019 Jun; 104(6):1237-1243. PubMed ID: 30923095
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, pharmacodynamics, and platelet binding of an anti-glycoprotein IIb/IIIa monoclonal antibody (7E3) in the rat: a quantitative rat model of immune thrombocytopenic purpura.
Hansen RJ; Balthasar JP
J Pharmacol Exp Ther; 2001 Jul; 298(1):165-71. PubMed ID: 11408538
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic autoimmune thrombocytopenia: evidence for redistribution of platelet antibodies into the circulation after immunoadsorption treatment.
Leitner GC; Stiegler G; Horvath M; Hoecker P; Sagaster P; Panzer S
Am J Hematol; 2003 May; 73(1):44-7. PubMed ID: 12701120
[TBL] [Abstract][Full Text] [Related]
11. Identification of mimotopes of platelet autoantigens associated with autoimmune thrombocytopenic purpura.
Gevorkian G; Manoutcharian K; Govezensky T; Cano JA; Dominguez V; Santamaria H; Larralde C
J Autoimmun; 2000 Aug; 15(1):33-40. PubMed ID: 10936026
[TBL] [Abstract][Full Text] [Related]
12. Platelet function and immune response.
Kekomäki R
J Pediatr Hematol Oncol; 2003 Dec; 25 Suppl 1():S19-23. PubMed ID: 14668634
[TBL] [Abstract][Full Text] [Related]
13. Quantitative comparisons of antibody-binding sites of platelet glycoprotein IIb/IIIa in aplastic anemia and idiopathic thrombocytopenic purpura.
Kahng J; Park HH; Han K; Choi BY; Lee W
Ann Clin Lab Sci; 2008; 38(1):6-11. PubMed ID: 18316775
[TBL] [Abstract][Full Text] [Related]
14. [Autoreactive T cells involved in pathogenesis of ITP as a target for immune therapy].
Kuwana M
Rinsho Ketsueki; 2000 Jun; 41(6):454-7. PubMed ID: 10921340
[No Abstract] [Full Text] [Related]
15. Human/BALB radiation chimera engrafted with splenocytes from patients with idiopathic thrombocytopenic purpura produce human platelet antibodies.
Dekel B; Marcus H; Shenkman B; Shimoni A; Shechter Y; Canaan A; Berrebi A; Varon D; Reisner Y
Immunology; 1998 Jul; 94(3):410-6. PubMed ID: 9767425
[TBL] [Abstract][Full Text] [Related]
16. Relative efficacy of steroid therapy in immune thrombocytopenia mediated by anti-platelet GPIIbIIIa versus GPIbα antibodies.
Zeng Q; Zhu L; Tao L; Bao J; Yang M; Simpson EK; Li C; van der Wal DE; Chen P; Spring CM; Wang M; Zhang L; Ruan C; Hou M; Xia R; Ni H
Am J Hematol; 2012 Feb; 87(2):206-8. PubMed ID: 22139961
[TBL] [Abstract][Full Text] [Related]
17. Predominant autoantibody response to GPIb/IX in a regulatory T-cell-deficient mouse model for immune thrombocytopenia.
Nishimoto T; Satoh T; Simpson EK; Ni H; Kuwana M
J Thromb Haemost; 2013 Feb; 11(2):369-72. PubMed ID: 23176290
[No Abstract] [Full Text] [Related]
18. Characterization of glycoprotein IIb/IIIa-specific alloantibodies induced by cross-strain platelet immunization in mice.
Bougie DW; Sutton J; Aster RH
Transfusion; 2021 Apr; 61(4):1278-1285. PubMed ID: 33483962
[TBL] [Abstract][Full Text] [Related]
19. Anti-alphavbeta3 antibodies in chronic immune thrombocytopenic purpura.
Kosugi S; Tomiyama Y; Honda S; Kashiwagi H; Shiraga M; Tadokoro S; Kiyoi T; Kurata Y; Matsuzawa Y
Thromb Haemost; 2001 Jan; 85(1):36-41. PubMed ID: 11204584
[TBL] [Abstract][Full Text] [Related]
20. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
